RCPA - Rehabilitation and Community Providers Association


Guidelines For Comment: Atypical Antipsychotic Agents and Suboxone/Subutex
March 4, 2009

At the recent Medical Assistance Advisory Committee meeting, proposed prior authorization and medical necessity guidelines for items of interest to the Mental Health and Drug and Alcohol Committees were distributed for review and comment. Guidelines for atypical antipsychotic agents prescribed outside of the Food and Drug Administration approved dosing limits and for Suboxone/Subutex (buprenorphine) were distributed. Committee members, or other agency staff, may wish to comment on these guidelines, which are available from the links above as PDF files.  Any comments should be addressed directly to c-crussell@state.pa.us by March 12. PCPA would appreciate a copy of any comments that are submitted; these should be sent to Betty Simmonds (betty@paproviders.org). Thank you for your efforts.

< Back